KBR工程 KBR 深 沪
已收盘 05-29 16:00:00 美东时间
34.95
+0.510
+1.48%
华盛通- 最 高36.05
- 今 开34.14
- 成交量 397.81万股
- 最 低 34.00
- 昨 收 34.44
- 总市值 44.31亿
- 52周最高 53.88
- 市盈率 静 10.02
- 换手率 3.14%
- 52周最低 29.94
- 委 比 99.71%
- 总股本 1.27亿
- 历史最高 71.625
- 量 比 2.42
- 振 幅 5.95%
- 历史最低 7.04
- 每 手 1
- 风险率 5.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多KBR's Proprietary PureSAF Technology Selected By NorSAF For The Largest Production Plant In Northern Europe
Under the agreement, KBR will license the proprietary PureSAF® technology, invented and developed by Swedish Biofuels AB for NorSAF's new plant, which is expected to produce 100,000 tons of sustainable aviation fuel
05-28 18:07
美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
UBS Maintains Neutral on KBR, Lowers Price Target to $36
UBS analyst Steven Fisher maintains KBR (NYSE:KBR) with a Neutral and lowers the price target from $42 to $36.
05-22 04:37
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Citigroup Maintains Buy on KBR, Lowers Price Target to $50
Citigroup analyst Andrew Kaplowitz maintains KBR (NYSE:KBR) with a Buy and lowers the price target from $53 to $50.
05-07 02:54
KBR shares are trading lower. The company reported its Q1 financial results.
KBR shares are trading lower. The company reported its Q1 financial results.
05-06 02:06
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
财报速睇 | KBR工程 2026财年Q2营收19.23亿美元，同比下降4.7%；归母净利润1.02亿美元，同比下滑12.1%
华盛资讯5月5日讯，KBR工程公布2026财年Q2业绩，公司Q2营收19.23亿美元，同比下降4.7%，归母净利润1.02亿美元，同比下滑12.1%。
05-05 18:40
KBR Affirms FY2026 Adj EPS Guidance of $3.87-$4.22 vs $3.98 Est; Affirms FY2026 Sales Guidance of $7.900B-$8.360B vs $8.044B Est
KBR (NYSE:KBR) affirms FY2026 Adj EPS guidance from $3.87-$4.22 to $3.87-$4.22 vs $3.98 analyst estimate. Affirms FY2026 sales outlook from $7.900 billion-$8.360 billion to $7.900 billion-$8.360 billion vs $8.044 billion
05-05 18:02
What's Going On With KBR Stock Thursday?
KBR stock eyes $38.50 resistance after key wins. Analysis of the $510M IDIQ contract, lithium strategy, and May 5 earnings outlook.
04-30 20:22
